PPT-A Cost-Benefit Assessment of Abuse Deterrent Opioids

Author : ellena-manuel | Published Date : 2017-12-07

Wayne Winegarden PhD Sr Fellow Business amp Economics Pacific Research Institute Contributing Editor EconoSTATS a project of George Mason University Partner Capitol

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "A Cost-Benefit Assessment of Abuse Deter..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

A Cost-Benefit Assessment of Abuse Deterrent Opioids: Transcript


Wayne Winegarden PhD Sr Fellow Business amp Economics Pacific Research Institute Contributing Editor EconoSTATS a project of George Mason University Partner Capitol Economic Advisors Presentation CWAG Annual Conference. Identifying . indicators of good prescribing and problem use in . primary care. Nicola . Torrance. Research Fellow. Chronic Pain Research . Group. http. ://medicine.dundee.ac.uk/chronic-pain. . Adverse effects. Outpatient Opioid Therapy: Mitigating Risks. Perry G. Fine, MD . Professor . of Anesthesiology. Department . of . Anesthesiology . School . of Medicine. University of Utah. O. bjectives. Be informed of content, intent and limitation of current Clinical Guidelines. . Melissa B. Weimer, DO, MCR. Disclosures. Dr. Weimer is a consultant for . INFORMed. , IMPACT education, and the American Association of Addiction Psychiatry.. Dr. Weimer is the medical director of CODA, Inc. . Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None.      Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill.  He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship.  While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972.  For this he receive the  Meritorious Service Medal.  He has practiced adult psychiatry in Grand Junction for 28 years.  He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Emerging knowledge and clinical experience. Conflict of Interest. None to declare. Objectives. Brief . overview of areas of emerging knowledge . F. acilitated discussion of clinical experiences and evolution . Opiates bind to receptors in the brain, which means that they kill pain by preventing the transmission of pain impulses in the brain, rather than at the source.. Opiates are derived from opium, which is found in poppy seeds. . The Epidemic. Chronic Pain and Prescription Opioids. 11% of Americans experience daily (chronic) pain. Opioids frequently prescribed for chronic pain. Primary care providers commonly treat chronic, non-cancer pain. Stimulants: . Opinions . of the Medical . Expert Panel regarding Commercial Driver Performance and Crash Risk. Presenter: . Mitchell A. . Garber,. MD, MPH, MSME, Senior Managing Consultant, Engineering Systems, Inc. . Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Daniel Ford, PharmD, BCPS, BCCCP. Pharmacy Clinical Practice Manager. Pharmacy Residency Program Director. NorthBay Healthcare. ?. Itinerary. Stereotypes. Weekend Warrior. Long standing arthritic. “My . FDA’s Role and . Emerging Challenges. Jeanne Ireland. Principal, Ireland Strategies, LLC. 2015 CWAG Annual Meeting. The Opioid Epidemic. Some progress being made, but devastating effects of epidemic continue. Psycho-Education for Patients and Family Members. 12-. 1. The Importance of Total Abstinence. Abstinence from all substances that affect the brain—even alcohol—greatly increases the chances of a successful recovery.. with . Traumatic Brain Injury . Shashank J. Davé, DO, FAAPMR. Clinical Associate Professor. Department of Physical Medicine & Rehabilitation. Department of Neurology. Indiana University School of Medicine. A . Ganar. in Honduras. Bingying Wu, University of Maryland. Client: Social Impact, Inc.. May 16. th. , 2017 . The World Bank, Washington D.C.. A . Ganar. Program. Overview. Youth workforce development and employability skills through sports .

Download Document

Here is the link to download the presentation.
"A Cost-Benefit Assessment of Abuse Deterrent Opioids"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents